XML 41 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Goodwill and Other Intangible Assets, Net (Tables)
9 Months Ended
Sep. 30, 2017
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of goodwill
The following table provides a summary of the activity in goodwill by segment for the nine month period ended September 30, 2017 (in thousands):
 
Consumer
Health
 
Prescription
Pharmaceuticals
 
Total
Balances at December 31, 2016
$
16,717

 
$
267,576

 
$
284,293

Currency translation adjustments

 
629

 
629

Acquisitions

 

 

Impairments

 

 

Dispositions

 

 

Balances at September 30, 2017
$
16,717

 
$
268,205

 
$
284,922

Schedule of other intangible assets
The following table sets forth the major categories of the Company’s intangible assets as of September 30, 2017 and December 31, 2016, and the weighted average remaining amortization period as of September 30, 2017 and December 31, 2016 (dollar amounts in thousands):

 
Gross
Amount (1)
 
Accumulated
Amortization
 
Reclass-ifications
 
Gross Impairment
 
Net
Balance
 
Wtd Avg Remaining
Amortization Period
(years)
September 30, 2017
 
 
 
 
 
 
 
 
 
 
 
Product licensing rights
$
744,812

 
$
(222,221
)
 
$

 
$
(14,557
)
 
$
508,034

 
9.8
IPR&D
173,757

 

 

 
(3,415
)
 
170,342

 
N/A - Indefinite lived
Trademarks
16,000

 
(5,144
)
 

 

 
10,856

 
18.0
Customer relationships
4,225

 
(1,993
)
 

 

 
2,232

 
8.6
Other intangibles
11,235

 
(5,614
)
 

 

 
5,621

 
5.7
 
$
950,029

 
$
(234,972
)
 
$

 
$
(17,972
)
 
$
697,085

 
 
December 31, 2016
 

 
 

 
 
 
 
 
 

 
 
Product licensing rights
$
790,143

 
$
(182,901
)
 
$
9,400

 
$
(52,637
)
 
$
564,005

 
10.5
IPR&D
187,007

 

 
(9,400
)
 
(3,850
)
 
173,757

 
N/A - Indefinite lived
Trademarks
16,000

 
(4,244
)
 

 

 
11,756

 
18.0
Customer relationships
6,290

 
(3,863
)
 

 

 
2,427

 
9.3
Other intangibles
11,235

 
(4,326
)
 

 

 
6,909

 
6.0
 
$
1,010,675

 
$
(195,334
)
 
$

 
$
(56,487
)
 
$
758,854

 
 


(1) Differences in the Gross Amounts between periods are due to either impairment of assets or the write down of fully amortized assets.